New pill takes on tough blood cancers in first human trial
Disease control
Recruiting now
This early-phase trial tests an experimental oral drug called UBX-303061 in 94 adults with B-cell blood cancers (like certain lymphomas and leukemias) that have come back or not responded to at least two prior treatments. The main goals are to check safety, find the right dose, a…
Phase: PHASE1 • Sponsor: Ubix Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC